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Abstract:  Our previous study indicated that both 17β-estradiol (E2), known to be an 
endogenous estrogen, and bisphenol A (BPA), known to be a xenoestrogen, could 
positively influence the proliferation or differentiation of neural stem/progenitor cells 
(NS/PCs). The aim of the present study was to identify the signal transduction pathways 
for estrogenic activities promoting proliferation and differentiation of NS/PCs via well 
known nuclear estrogen receptors (ERs) or putative membrane-associated ERs. NS/PCs 
were cultured from the telencephalon of 15-day-old rat embryos. In order to confirm the 
involvement of nuclear ERs for estrogenic activities, their specific antagonist, ICI-182,780, 
was used. The presence of putative membrane-associated ER was functionally examined as 
to whether E2 can activate rapid intracellular signaling mechanism. In order to confirm the 
involvement of membrane-associated ERs for estrogenic activities, a cell-impermeable E2, 
bovine serum albumin-conjugated E2 (E2-BSA) was used. We showed that E2 could 
rapidly activate extracellular signal-regulated kinases 1/2 (ERK 1/2), which was not 
inhibited by ICI-182,780. ICI-182,780 abrogated the stimulatory effect of these estrogens 
(E2 and BPA) on the proliferation of NS/PCs, but not their effect on the differentiation of 
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the NS/PCs into oligodendroglia. Furthermore, E2-BSA mimicked the activity of 
differentiation from NS/PCs into oligodendroglia, but not the activity of proliferation. Our 
study suggests that (1)  the estrogen induced proliferation of NS/PCs is mediated  via 
nuclear ERs; (2) the oligodendroglial generation from NS/PCs is likely to be stimulated via 
putative membrane-associated ERs. 
Keywords: 17β-estradiol; bisphenol A; estrogen; neural stem cell; oligodendrocytes; 
proliferation; differeciation 
 
1. Introduction  
Embryonic neural stem cell (NSC)-transplantation or endogenous NSC-activation is a recent 
challenging approach for the treatment of neurological diseases or injuries to the central nervous 
system (CNS) [1–3]. NSCs comprise most of the progenitor cells (PCs) in the CNS [4,5] and are 
capable of self-renewal and multipotent differentiation into the three cell types of the CNS (neurons, 
astrocytes, and oligodendrocytes). The NSC-based therapies should be of note as the stem cell 
microenvironment or niche is important as various external signals have been shown to play a role in 
regulating their proliferation and differentiation [6]. Estrogens (female estrogenic hormones such as 
17β-estradiol (E2) and estrogen-like endocrine-disrupting chemicals such as bisphenol A (BPA), etc.) 
are candidates for extrinsic regulators [7–10]. Our previous study  showed that both E2 and BPA 
influence the fate of neural stem/progenitor cells (NS/PCs) when the cells are poorly supplied with 
mitogens or differentiation factors [10]. The aim of the present study was to investigate the underlying 
molecular mechanisms of estrogen actions on the proliferation and differentiation of NS/PCs. 
Many estrogenic actions are known to be mediated via nuclear estrogen receptors (ERs), ERα and 
ERβ. Nuclear ERs function as ligand-activated transcription factors to regulate the expression of 
estrogen-responsive genes (ERE) [11]. In addition to nuclear ERs, membrane-associated ERs have 
recently been suggested to exist and to function, because some estrogenic effects occur within seconds 
to minutes, which is a finding that cannot be explained by a nuclear ER-mediated mechanism [12,13]. 
Investigations of nonclassical estrogen signaling suggest that ERα and ERβ, or ER-like proteins, are 
likely to be the membrane ERs in each target cells, and GPR-30, the orphan G protein-coupled 
receptors (GPCR)-like protein, was suggested to be one of the candidates of ER-like proteins [14,15]. 
Thus, to put it another way, the present study is aimed at identifying the signal transduction pathways 
for estrogenic activities promoting proliferation and differentiation of NS/PCs via well known nuclear 
ERs or putative membrane-associated ERs.  
We have already confirmed that NS/PCs express both types of nuclear ERs [10], while even the 
existence of membrane-associated ERs has not yet been determined on NS/PCs. In various cells, the 
existence of membrane-associated ERs can be functionally confirmed [12,13]. Many reports have 
shown that E2 activates extracellular signal-regulated kinases (ERK)1/2, components of the 
mitogen-activated protein kinase (MAPK) signaling cascade, via membrane-associated ER, and that 
the activation of ERK1/2 is likely to be a key event to discriminate signal cascades dependent on ERs 
from those depending on non-nuclear ERs [16–19]. In the present study, we thus examined whether Int. J. Mol. Sci. 2010, 11                 
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ERK 1/2-activation is shown in our NS/PCs after the treatment by estrogens in order to investigate the 
existence of membrane-associated ERs. 
In order to confirm the participation of nuclear ERs on the estrogen actions, we investigated the 
protective efficacy of ICI-182,780 on the proliferation and differentiation of NS/PCs. ICI-182,780, a 
7α–alkylsulfinyl analog of E2 [20], is able to bind to both ERα and ERβ with an affinity comparable to 
that of E2; and micromolar concentrations of this antagonist have been used to inhibit estrogen 
function [21]. In order to confirm the participation of putative membrane-associated ERs on the 
estrogen actions, we investigated the effect of a cell-impermeable E2, bovine serum 
albumin-conjugated E2 (E2-BSA) [17], on the proliferation or oligodendroglial differentiation of 
cultured NS/PCs.  
2. Materials and Methods 
2.1. Reagents 
E2, BPA, and β-estradiol 6-(O-carboxymethyl)oxime: bovine serum albumin (E2-BSA), U0126 
were purchased from Sigma (St. Louis, MO, USA). ICI-182,780 was obtained from Tocris (Ellisville, 
MO, USA). E2-BSA was separated from free E2 by use of a centrifugal filter, Microcon YM-30 
(Millipore, Billerica, MA, USA). The E2-BSA used in this study was composed of BSA conjugated 
with 33 molecules of E2, i.e., 3 × 10
-10 M E2-BSA was equivalent to 10
-8 M E2.  
2.2. Primary Cultures  
As previously described in detail [10], NS/PCs were prepared from the telencephalon of Wistar rats 
(Nippon SLC, Shizuoka, Japan) at E15, propagated by the neurosphere method, and then plated on 
poly-L-ornithine-coated plates or dishes for the experiments. The proliferation medium consisted of 
Dulbecco's modified Eagle's minimum essential medium nutrient mixture F-12 HAM (DMEM/F12) 
supplemented with insulin (25 μg/mL), apo-transferrin (100 μg/mL), progesterone (20 nM), putrescine 
(100  μM), sodium selenite (30 nM), penicillin (100 U/mL), and streptomycin (100 μg/mL). The 
required amount of FGF-2 (R&D Systems, Minneapolis, MN, USA) was added to the medium every 
day to achieve a final concentration of 10 ng/mL.  
2.3. Western Immunoblot Analysis  
Cells were plated on 6-well plates (1 × 10
5 cells/cm
2), and cultured for three days in the 
proliferation medium, for an additional day in FGF-2-free medium, then incubated with test drugs for 
various times, and the cell extracts were prepared as previously described [22]. The antibodies and 
their sources were the following: rabbit antibody against MAPK 1/2 (Erk1/2-CT) which recognizes the 
C-terminal 35 amino acids of the rat 44 kDa MAPK1/ERK1 and 42 kDa MAPK2/ERK2, from Upstate 
(Lake Placid, NY, USA); rabbit antibodies against phospho-p44/42 MAPK (Thr202/Tyr204) which 
recognizes the phosphorylated ERK1/2 (pERK1/2) from Cell Signaling (Danvers, MA, USA); and 
alkaline phosphatase-conjugated anti-rabbit IgG (H + L), from Promega (Madison, WI, USA).  
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2.4. BrdU Labeling 
Cells were plated on micro slide/cover glasses (Matsunami Glass Ind. Ltd., Osaka, Japan) in 
24-well plates (6 × 10
4 cells/well) and cultured for three days in the proliferation medium, for an 
additional day in FGF-2-free medium containing the test compound, and then for 2 h in the presence of 
10 μM 5-bromo-2’-deoxyuridine (BrdU; Sigma). The number of BrdU-positive cells was determined 
by an immunocytochemical technique using anti-BrdU mouse antibody (Sigma) and rhodamine-
labeled anti-mouse IgG antibodies (Chemicon, Temecula, CA, USA), as described previously [10]. 
The total number of cells and the number of BrdU-positive cells (Figure 2A) were counted in seven 
arbitrarily selected fields of each well. For each treatment, 4–8 wells were analyzed; and the 
experiments were repeated more than three times. For statistical analysis Student’s t-test was used. 
2.5. MTT Assay  
As described previously [10], cells were plated (2 × 10
4 cells/well) in 96-well plates and cultured 
for three days in the proliferation medium, for an additional day in FGF-2-free medium containing the 
test compound, and then for 4 h in the presence of 0.5 mg/mL of 3-[4,5-dimethyl-2-thiazolyl]-2,5-
diphenyl tetrazolium bromide (MTT; Sigma). After the crystals had been dissolved in 
HCl/isopropanol, the absorbance at 570 nm was determined by using a micro plate reader (Bio-Rad, 
model 550). The cell number compared with that of the ethanol-treated control group was presented as 
a fold-increase. The total MTT converted to formazan by the cells (i.e., total cell number) in all of the 
wells, had an absorbance that ranged from 0.2 to 0.75 at 570 nm.  
2.6. Immunocytochemistry  
Cells were plated on micro slide/cover glasses that had been placed in 24-well plates filled with the 
proliferation medium (4 × 10
4 cells/well), and cultured for three days. They were then reacted for 
another five days with the test compound prepared in FGF-2-free medium. Immunocytochemical 
analysis was performed as described previously [10] using anti-nestin mouse antibody, anti-NG2 rabbit 
antibody (Chemicon), anti-βIII tubulin (Tuj-1) mouse antibody, anti-glial fibrillary acidic protein 
(GFAP) mouse antibody, anti-2’3’-cyclic nucleotide 3’-phosphodiesterase (CNPase) mouse antibody 
(Sigma), and rhodamine-labeled anti-mouse IgG antibody (Promega) or rhodamine-labeled anti-rabbit 
IgG antibodies (Chemicon). The total number of cells and the number of immunoreactive cells were 
counted in seven arbitrarily selected fields of each well. For each treatment, 4–8 different wells were 
analyzed, and the experiments were repeated more than three times. For statistical analysis, Student’s 
t-test was used. 
3. Results and Discussion 
3.1. Effect of Estrogens on the Phosphorylation of MAPK/ERK of NS/PCs 
In order to functionally confirm the existence of membrane-associated ERs on NS/PCs, we assessed 
the effect of estrogens on the activation (phosphorylation) of ERK1/2 in the cultured NS/PCs. Our 
previous study showed that 2 ERK isoforms (ERK1 and ERK2) are present in NS/PCs [22]. As shown Int. J. Mol. Sci. 2010, 11                 
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in Figure 1A, pERK1/2 increased transiently 15 min after the exposure of the cells to E2 at a 
concentration of 10
-8 M, and declined to the control level 30 min after exposure, presenting the 
possibility that functional membrane-associated ERs were expressed on the NS/PCs and responded to 
E2 exposure.  
When cells were pretreated with ICI-182,780, the activation of ERK2 induced by E2 was not 
blocked (Figure 1B) as previously indicated [23,24]. The reason why we analyzed the ratio of 
phosphorylated ERK2 (pERK2) per total ERK2 in Figure 1B is that only the ERK2 isoform has been 
suggested to be attributable to neural development [25] although ERK1 and ERK2 exhibit 84 % 
sequence homology and are coordinately activated through the MAPK cascade. The pretreatment with 
U0126, a selective inhibitor of MAPK kinase (MEK), inhibited E2-induced phosphorylation of ERK2 
(Figure 1B), indicating the phosphorylation of ERK1/2 elicited by estrogen to be MEK dependent. 
These results suggested the possibility that our NS/PCs express membrane ERs. 
Figure 1. Effect of E2 on the phosphorylation of ERK of NS/PCs. (A) Cells were treated 
with 10
-8 M E2 for the indicated times. The immunoreactive bands of pERK1/2 and 
ERK1/2 were scanned for intensity. (B) Cells were treated for 15 min with 10
-8 M E2 after 
pretreatment for 1 h with 10
-6  M ICI-182,780 or 30 min with 10
-5  M U0126. The 
immunoreactive bands of pERK and ERK were scanned for intensity, and the ratios of 
pERK2/ERK2 are shown in the panel. Significant differences in values between the 
estrogen-treated and non-treated cells (**P < 0.01; Student’s t test) and in those indicated 
by the brackets are shown (
##P < 0.01; Student’s t test, NS; not significant). 
 
 
 
 
 
 
 
3.2. Mechanism of Action of Estrogens on Proliferation of NS/PCs  
We previously showed that the administration of E2 or BPA to the NS/PCs stimulated their 
proliferation in the absence, but not in the presence, of FGF-2 [10]. In order to investigate whether the 
stimulatory effects of estrogens on the proliferation of NS/PCs were mediated through nuclear ERs, we 
pretreated cells for 1 h with 10
-6 M ICI-182,780 before exposure to 10
-8 M E2 or 10
-5 M BPA for 24 h, 
and then determined the percentages of the cells in the S phase of the cell cycle by using the BrdU 
labeling method. As shown in Figure 2B and 2C, E2 and BPA, respectively, significantly increased the 
number of BrdU-positive cells compared with their number among the control cells; and pretreatment 
with ICI-182,780 significantly inhibited their effect. ICI-182,780 alone did not significantly decrease 
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the BrdU-positive cells (not shown). These results suggest that the estrogens had the ability to 
stimulate proliferation of NS/PCs via nuclear ERs.  
Figure 2. Effect of E2 or BPA, with or without ICI-182,780 pretreatment. on cell 
proliferation of NS/PCs, by measuring the incorporation of the thymidine analogue BrdU. 
The BrdU-positive cells were immunocytochemically examined (A), and their percentage 
in the presence of E2 (B) or BPA (C) with or without ICI-182,780 pretreatment is shown 
on the ordinate. The ratios of the value for the estrogen-treated cells to that value for the 
control cells (ethanol-treated cells) were calculated, and are shown on the ordinate. Values 
are presented as the mean ± SEM (n = 4–8, different cultures). Significant differences in 
values between the estrogen-treated and non-treated cells (**P < 0.01; Student’s t test) and 
in those indicated by the brackets are shown (
#P < 0.05, 
###P < 0.001; Student’s t test). 
 
 
We also checked the effect of the pretreatment with ICI-182,780 on the E2- or BPA-induced 
proliferation by use of the MTT assay. As shown in Figure 3A, compared with the MTT signals 
(indicating viable cells) from the non-treated control group, those from the E2-treated group were 
significantly greater; and pretreatment with ICI-182,780 significantly suppressed this effect. The cell 
number was unchanged when the cells were treated with ICI-182,780 alone (not shown). Figure 3B 
shows that similar results were obtained with BPA. These results confirmed those evaluated by the 
BrdU labeling experiment that the nuclear ERs participated in the stimulatory effect of estrogens on 
NS/PC proliferation. 
In order to investigate the participation of putative membrane-associated ERs on the estrogen 
actions, we cultured NS/PCs for 24 h in FGF-2-free medium containing 3 × 10
-10  M E2-BSA 
(equivalent to 10
-8 M E2), a membrane-impermeable E2 conjugate, instead of E2. As shown in Figure 
3C, E2-BSA did not increase the MTT signal intensity, thus suggesting that the membrane-associated 
ERs did not participate in the proliferation of NS/PCs. As expected, ICI-182,780 did not affect the cell 
number in the presence of E2-BSA. 
Previous reports have shown the proliferative effect of E2 [7,8] and BPA [26] on cultured 
embryonic NSCs, though the action mechanisms involved in signal transduction were unknown. This 
is the first report suggesting a role for nuclear ERs in estrogen-induced proliferation of NS/PCs. It is 
now established that agonist-bound ERα has a strong positive effect on cell proliferation of several cell 
models including breast cancer cells [27]. Our NS/PCs expressed predominantly ER mRNA rather 
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than the ERmRNA that was predominant in neurons [10]. It will be necessary to clarify which 
ERhas the most impact on proliferation of NS/PCs. 
Figure 3. Effect of E2, BPA or E2-BSA, with or without ICI-182,780 pretreatment on cell 
proliferation of NS/PCs, by measuring the MTT assay. NS/PCs were pretreated or not with 
10
-6 M ICI-182,780 for 1 h, treated with E2 (A), BPA (B) or E2-BSA (C) for 24 h, and 
then subjected to the MTT assay. Values are presented as the mean ± SEM (n = 4–8, 
different cultures). Significant differences in values between the estrogen-treated and 
non-treated cells (***P < 0.001; Student’s t test) and in those indicated by the brackets are 
shown (
##P < 0.01, 
###P < 0.001; Student’s t test; NS, not significant). 
 
 
 
 
 
 
 
 
3.3. Mechanism of Action of Estrogens on Differentiation of NS/PCs  
We previously showed that E2- or BPA-treatment increased the ratio of the oligodendrocytes 
generated from the NS/PCs to total cells; however, this ratio did not change when the cells were 
stimulated with platelet-derived growth factor (PDGF) or with neurotrophin-3 [10]. We tested the 
action mechanisms of these estrogens on the differentiation of NS/PCs into oligodendroglia. NS/PCs 
were pretreated for 1 h with or without 10
-6 M ICI-182,780, and cultured for five days in FGF-2-free 
medium containing 10
-8 M E2. Figure 4 shows that the proportion of nestin-positive (immature neural 
stem cells), Tuj-1-positive (neurons) and GFAP-positive (astrocytes) cells did not change significantly, 
but the percentage of CNPase-positive (oligodendrocytes) cells was significantly increased by 
E2-treatment as previously shown [10]; and that the pretreatment of the cells with ICI-182,780, a 
classical ER antagonist, did not affect the percentage of these positive cells. 
We then pretreated NS/PCs for 1 h with or without 10
-6 M ICI-182,780 and cultured for five days in 
FGF-2-free medium containing 10
-8 M E2, 10
-5 M BPA or 3 × 10
-10 M E2-BSA. As shown in Figure 5, 
the percentage of NG2-positive oligodendrocyte precursor cells in the NS/PC cultures was 
significantly increased by BPA or E2-BSA as well as E2 (closed bar) compared with the percentage in 
control cultures (open bar), and the pretreatment of the cells with ICI-182,780 did not reverse the 
differentiation-inducing effect of E2, BPA or E2-BSA (shaded bar). ICI-182,780 alone did not affect 
the percentage of the NG-2-positive cells (data not shown).  
These results suggested that estrogen-induced glial generation from NS/PCs was mediated, not 
through nuclear ERs, but probably through membrane-associated ERs. Recently evidence was 
presented that STX, a synthetic selective ER modulator, and G1, the GPR-30 agonist, are beneficial 
tools as non-classical ER agonist [28]. Both STX and G1 do not bind to or activate the nuclear ERs, 
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but activate MAPK pathway. It will be necessary to investigate the effect of these compounds on 
NS/PCs in near future. 
Figure 4. Effect of E2-treatment and/or ICI-182,780-pretreatment on the differentiation of 
NS/PCs. The cells were examined by immunocytochemistry using anti-nestin, anti-Tuj-1, 
anti-GFAP or anti-CNPase antibodies (Scale bar = 50 μm) (A). The percentage of cells 
positive for each marker was calculated, and is shown on the ordinate (B). Their values 
were expressed as the mean ± SEM (n = 4–16). Significance, *p < 0.05, **p < 0.01 versus 
control; Student’s t test.  
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Effect of E2, BPA, or E2-BSA with or without ICI-182,780-pretreatment on the 
oligodendroglial differentiation of NS/PCs. The cells were examined by 
immunocytochemistry using  anti-NG2 antibodies (Scale bar = 50 μm) (A), and NG2-
positive cells in the various cultures was determined. Their values in the presence of E2 
(B), BPA (C) or E2-BSA (D) are expressed as the mean ± SEM (n = 4–16) on the ordinate. 
Significance, *p < 0.05, **p < 0.01 versus control; Student’s t test. NS, not significant. 
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4. Conclusions 
This study demonstrates that the estrogen-induced proliferation of NS/PCs was mediated  via 
nuclear ERs, and suggests that the oligodendroglial generation from NS/PCs was stimulated by 
putative membrane-associated ERs. 
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